Cisatracurium Besylate 31722-0313-10

Package NDC

31722-0313-10

Manufacturer: Camber Pharmaceuticals Inc.
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: May 4, 2026
Listing Expires: December 31, 2027
Application: ANDA212432

Need to source Cisatracurium Besylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Cisatracurium Besylate	2 mg/mL

Drug Class

Neuromuscular Nondepolarizing Blockade [PE]Nondepolarizing Neuromuscular Blocker [EPC]

Selected Package

31722-0313-10Selected

10 VIAL, SINGLE-DOSE in 1 CARTON (31722-313-10) / 5 mL in 1 VIAL, SINGLE-DOSE (31722-313-02)